![Michael Kalb](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Kalb
Finanzdirektor/CFO bei
CATALYST PHARMACEUTICALS, INC.
Vermögen: 426 758 $ am 31.05.2026
Profil
Michael W.
Kalb is Chief Financial Officer & Executive Vice President at Catalyst Pharmaceuticals, Inc. since 2024.
Former roles include Executive VP, Chief Financial & Accounting Officer at CinCor Pharma, Inc. from 2022 to 2023; Chief Financial Officer at IPI Legacy Liquidation Co. in 2023; Chief Financial Officer & Senior Vice President at Amarin Corp.
Plc from 2016 to 2022; Chief Financial & Accounting Officer, Group VP at Taro Pharmaceutical Industries Ltd. from 2013 to 2016; Chief Financial Officer at Taro Pharmaceuticals U.S.A., Inc.; and Director-Accounting & Financial Consulting Group at Huron Consulting Group, Inc. Education includes undergraduate studies at State University of New York at Albany.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 27.04.2026 | 13.665 ( 0,01 % ) | 426 758 $ | 31.05.2026 |
Aktive Positionen von Michael Kalb
| Unternehmen | Position | Beginn |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 01.01.2024 |
Ehemalige bekannte Positionen von Michael Kalb
| Unternehmen | Position | Ende |
|---|---|---|
| IPI LEGACY LIQUIDATION CO | Finanzdirektor/CFO | 31.12.2023 |
| CINCOR PHARMA, INC. | Finanzdirektor/CFO | 01.03.2023 |
| AMARIN CORPORATION PLC | Finanzdirektor/CFO | 20.06.2022 |
| TARO PHARMACEUTICAL INDUSTRIES LTD. | Finanzdirektor/CFO | 29.06.2016 |
| HURON CONSULTING GROUP INC. | Comptroller/Controller/Auditor | - |
Ausbildung von Michael Kalb
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
43
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Amarin Corp. Plc
 Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
Taro Pharmaceutical Industries Ltd.
 Taro Pharmaceutical Industries Ltd. Medical/Nursing ServicesHealth Services Operates as a healthcare company that engages in therapies and generic medicines | Health Services |
Huron Consulting Group, Inc.
 Huron Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides healthcare, business advisory and education services | Commercial Services |
Catalyst Pharmaceuticals, Inc.
 Catalyst Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets novel medicines for patients living with rare diseases | Health Technology |
Impel Pharmaceuticals, Inc.
 Impel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late-stage biopharmaceutical company focused on developing transformative therapies for central nervous system disorders | Health Technology |
State University of New York at Albany
 State University of New York at Albany Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Taro Pharmaceuticals U.S.A., Inc.
 Taro Pharmaceuticals U.S.A., Inc. Pharmaceuticals: GenericHealth Technology Manufactures and sells generic pharmaceutical products | Health Technology |
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and trades medicines for cardiovascular, metabolic & kidney diseases | Health Technology |
